These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
The formulation is backed by over 80 clinical trials and 200 scientific publications
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
According to the ICMR-INDIAB study, 11.4% of adults in India have type 2 diabetes, while a staggering 15.3% are pre-diabetic
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
Subscribe To Our Newsletter & Stay Updated
